INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
PATIENT REVENUES, net	$ 118,630	$ 119,035	$ 354,145	$ 357,406
EXPENSES:
Operating	95,591	95,768	284,643	284,823
Lease and rent expense	13,251	12,060	39,480	36,105
Professional liability	1,737	1,604	5,182	4,898
Litigation contingency expense (Note 7)	0	6,400	3,100	6,400
General and administrative	6,902	6,873	21,267	23,046
Depreciation and amortization	2,279	2,662	6,812	7,686
Total expenses	119,760	125,367	360,484	362,958
OPERATING LOSS	(1,130)	(6,332)	(6,339)	(5,552)
OTHER INCOME (EXPENSE):
Gain on sale of investment in unconsolidated affiliate			0	308
Other income	25	0	207	113
Interest expense, net	(1,554)	(1,382)	(4,424)	(4,147)
Total other expense	(1,529)	(1,382)	(4,217)	(3,726)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(2,659)	(7,714)	(10,556)	(9,278)
BENEFIT FOR INCOME TAXES	741	252	(15,544)	903
LOSS FROM CONTINUING OPERATIONS	(1,918)	(7,462)	(26,100)	(8,375)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS:
Operating income (loss), net of tax benefit	(3,689)	65	(7,449)	564
Gain on disposal, net of tax	733	0	733	0
Income (loss) from discontinued operations	(2,956)	65	(6,716)	564
NET LOSS	$ (4,874)	$ (7,397)	$ (32,816)	$ (7,811)
Per common share – basic
Continuing operations (in dollars per share)	$ (0.30)	$ (1.17)	$ (4.04)	$ (1.32)
Discontinued operations (in dollars per share)	(0.45)	0.01	(1.04)	0.09
Net loss per common share – basic (dollars per share)	(0.75)	(1.16)	(5.08)	(1.23)
Per common share – diluted
Continuing operations (in dollars per share)	(0.30)	(1.17)	(4.04)	(1.32)
Discontinued operations (in dollars per share)	(0.45)	0.01	(1.04)	0.09
Net income (loss) per common share – diluted (dollars per share)	(0.75)	(1.16)	(5.08)	(1.23)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (dollars per share)	$ 0	$ 0.055	$ 0	$ 0.165
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,470	6,400	6,455	6,362
Diluted (shares)	6,470	6,400	6,455	6,362